FBRX
Forte Biosciences Inc
Price:  
23.51 
USD
Volume:  
92,592.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FBRX WACC - Weighted Average Cost of Capital

The WACC of Forte Biosciences Inc (FBRX) is 8.0%.

The Cost of Equity of Forte Biosciences Inc (FBRX) is 12.30%.
The Cost of Debt of Forte Biosciences Inc (FBRX) is 5.00%.

Range Selected
Cost of equity 9.90% - 14.70% 12.30%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.8% - 9.2% 8.0%
WACC

FBRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.32 1.75
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.90% 14.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.8% 9.2%
Selected WACC 8.0%